GAD1 and Cognitive impairment: GAD is a muscarinic receptor that enhances neuronal excitability and synaptic transmission, and scopolamine has an antagonistic effect on muscarinic receptors, which could alter synaptic and neuronal activities in the brain, leading to cognitive impairment (22).